Mark L. Fallick
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Reproductive Medicine top 10%
- Sperm and Testicular Function
Papers in
-
- Prostate Cancer Treatment and Research 5
- Prostate Cancer Diagnosis and Treatment 2
- Renal cell carcinoma treatment 2
-
- Urologic and reproductive health conditions 4
- Co-authors
- John P. Long (7 shared papers)Michael B. Atkins (1 shared paper)David F. McDermott (1 shared paper)William M. Rand (3 shared papers)Larry Lipshultz (4 shared papers)Angelo A. Ucci (1 shared paper)William W. Lin (2 shared papers)Daniel R. Saltzstein (3 shared papers)
- Journals
- The Journal of Urology (9 papers)Advances in Therapy (2 papers)Frontiers in Oncology (2 papers)Prostate Cancer and Prostatic Diseases (1 paper)JAMA Oncology (1 paper)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Mark L. Fallick
20 papers receiving 318 citations
Peers
Comparison fields: 5 of 43
- Pulmonary and Respiratory Medicine 222
- Reproductive Medicine 55
- Urology 27
- Cancer Research 45
- Rheumatology 35
Countries citing papers authored by Mark L. Fallick
This map shows the geographic impact of Mark L. Fallick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Fallick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Fallick more than expected).
Fields of papers citing papers by Mark L. Fallick
This network shows the impact of papers produced by Mark L. Fallick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Fallick. The network helps show where Mark L. Fallick may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark L. Fallick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 129 | |
| 2 | 1998 | 76 | |
| 3 | 1998 | 47 | |
| 4 | 1996 | 19 | |
| 5 | 1997 | 16 | |
| 6 | 1999 | 11 | |
| 7 | 2023 | 9 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 1997 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 1997 | 4 | |
| 13 | 1998 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 1999 | 2 | |
| 17 | Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate. | 1997 | 1 |
| 18 | 2025 | 1 | |
| 19 | 1997 | 1 | |
| 20 | 2023 | 1 |
About Mark L. Fallick
Mark L. Fallick is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Reproductive Medicine, Urology and Surgery, having authored 24 papers that have together received 349 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Urologic and reproductive health conditions (4 papers), Sperm and Testicular Function (3 papers), Genital Health and Disease (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Renal cell carcinoma treatment (2 papers), Hormonal and reproductive studies (2 papers) and Testicular diseases and treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (222 citations), Reproductive Medicine (55 citations), Urology (27 citations), Cancer Research (45 citations) and Rheumatology (35 citations). Mark L. Fallick has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include John P. Long, Michael B. Atkins, David F. McDermott, William M. Rand, Larry Lipshultz, Angelo A. Ucci, William W. Lin, Daniel R. Saltzstein, Neal D. Shore and Michael S. Cookson. Their work appears in journals such as The Journal of Urology, Advances in Therapy, Frontiers in Oncology, Prostate Cancer and Prostatic Diseases and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.